About this Journal Submit a Manuscript Table of Contents
Sarcoma
Volume 2013 (2013), Article ID 365723, 12 pages
http://dx.doi.org/10.1155/2013/365723
Research Article

Rapid Screening of Novel Agents for Combination Therapy in Sarcomas

1Chemical Biology and Molecular Medicine, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA
2Translational Research Lab, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA
3Small Animal Imaging Lab, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA
4Sarcoma Program, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA
5Anatomic Pathology Department, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA

Received 6 June 2013; Revised 4 September 2013; Accepted 5 September 2013

Academic Editor: Chandrajit Premanand Raut

Copyright © 2013 Christopher L. Cubitt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • John C. Dawson, and Neil O. Carragher, “Quantitative phenotypic and pathway profiling guides rational drug combination strategies,” Frontiers in Pharmacology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Damon R. Reed, Leo Mascarenhas, Kathleen Manning, Gregory A. Hale, John Goldberg, Jonathan Gill, Eric Sandler, Michael S. Isakoff, Tiffany Smith, Jamie Caracciolo, Richard M. Lush, Tzu-Hua Juan, Jae K. Lee, Anthony M. Neuger, and Daniel M. Sullivan, “Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies,” Cancer Medicine, 2015. View at Publisher · View at Google Scholar
  • Diana Yu, Elliot Kahen, Christopher L. Cubitt, Jeremy McGuire, Jenny Kreahling, Jae Lee, Soner Altiok, Conor C. Lynch, Daniel M. Sullivan, and Damon R. Reed, “Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma,” Scientific Reports, vol. 5, pp. 16991, 2015. View at Publisher · View at Google Scholar
  • Hua Chen, Jacson Shen, Edwin Choy, Francis J. Hornicek, and Zhenfeng Duan, “Targeting protein kinases to reverse multidrug resistance in sarcoma,” Cancer Treatment Reviews, vol. 43, pp. 8–18, 2016. View at Publisher · View at Google Scholar